Top compounds associated with response to GPRIN2


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib CCLE pan-cancer AAC 0.23 2e-06
mRNA lapatinib CCLE pan-cancer AAC 0.21 4e-06
mRNA Erlotinib gCSI pan-cancer AAC 0.25 7e-05
mRNA lapatinib gCSI pan-cancer AAC 0.22 0.0004
mRNA Vorinostat gCSI pan-cancer AAC -0.2 0.0009
mRNA Vandetanib CCLE pan-cancer AAC 0.16 0.001
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.12 0.002
mRNA OSI-027 CTRPv2 pan-cancer AAC -0.11 0.003
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA AZD8055 CTRPv2 pan-cancer AAC -0.11 0.003
Download CSV